Stockreport

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

NovaBridge Biosciences - American Depositary Shares  (NBP) 
PDF Givastomig, a potential best-in-class/first-in-class Claudin 18.2-directed bispecific antibody for gastric cancer, has shown robust and durable responses with broad CLD [Read more]